J-Lex

Besremi subcutaneous injection 500μg syringe

Besremi subcutaneous injection 500μg syringe, from Pharma Essentia Japan, contains Lopegine interferon alfa-2b (genetical recombination). This pegylated interferon is used for the treatment of certain myeloproliferative diseases. It is supplied as 500μg in 1mL per tube, with YJ code 4291467G2028.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).

More from this manufacturer